# Assessment of Intracellular Cytokines and Markers in Cells (Phase 3)

> **NCT03896100** · — · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Impression Cytology

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03896100
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2019-09-15
- **Final completion:** 2019-09-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03896100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03896100, "Assessment of Intracellular Cytokines and Markers in Cells (Phase 3)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03896100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*